Amgen's SWOT analysis: stock outlook amid obesity drug race
Amgen Inc (NASDAQ:AMGN)., a leading biopharmaceutical company with a market capitalization of $155 billion, is at a pivotal juncture as it navigates the competitive landscape of innovative ...
China has free health care and lower rates of obesity. Here’s how the life expectancy compares to the U.S.
The U.S. always seems to be in competition with China—economically, technologically, militarily. But how do the two countries stack up when it comes to measuring the health of its people? Going by ...